{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T02:40:53Z","timestamp":1684982453959},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,5,9]],"date-time":"2009-05-09T00:00:00Z","timestamp":1241827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00432-009-0593-5","type":"journal-article","created":{"date-parts":[[2009,5,8]],"date-time":"2009-05-08T05:54:51Z","timestamp":1241762091000},"page":"1455-1462","source":"Crossref","is-referenced-by-count":6,"title":["Endothelin-A-receptor antagonism with atrasentan exhibits limited activity on the KU-19-19 bladder cancer cell line in a mouse model"],"prefix":"10.1007","volume":"135","author":[{"given":"Edwin","family":"Herrmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"Tiemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Eltze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bolenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Persigehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lothar","family":"Hertle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"W\u00fclfing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,9]]},"reference":[{"key":"593_CR1","first-page":"720","volume":"59","author":"A Bagnato","year":"1999","unstructured":"Bagnato A, Salani D, Di Castro V, Wu-Wong JR, Tecce R, Nicotra MR, Venuti A, Natali PG (1999) Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth. Cancer Res 59:720\u2013727","journal-title":"Cancer Res"},{"key":"593_CR2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0002-9440(10)64032-1","volume":"158","author":"A Bagnato","year":"2001","unstructured":"Bagnato A, Rosano L, Di Castro V, Albini A, Salani D, Varmi M, Nicotra MR, Natali PG (2001) Endothelin receptor blockade inhibits proliferation of Kaposi\u2019s sarcoma cells. Am J Pathol 158:841\u2013847","journal-title":"Am J Pathol"},{"key":"593_CR3","first-page":"6381","volume":"62","author":"A Bagnato","year":"2002","unstructured":"Bagnato A, Cirilli A, Salani D, Simeone P, Muller A, Nicotra MR, Natali PG, Venuti A (2002) Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade. Cancer Res 62:6381\u20136384","journal-title":"Cancer Res"},{"key":"593_CR4","first-page":"251","volume":"14","author":"R Bartoletti","year":"2005","unstructured":"Bartoletti R, Cai T, Nesi G, Sardi I, Rizzo M (2005) Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up. Oncol Rep 14:251\u2013255","journal-title":"Oncol Rep"},{"key":"593_CR5","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00005344-200036051-00103","volume":"36","author":"LP Eberl","year":"2000","unstructured":"Eberl LP, Egidy G, Pinet F, Juillerat-Jeanneret L (2000) Endothelin receptor blockade potentiates FasL-induced apoptosis in colon carcinoma cells via the protein kinase C-pathway. J Cardiovasc Pharmacol 36:354\u2013356","journal-title":"J Cardiovasc Pharmacol"},{"key":"593_CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bjc.6700750","volume":"88","author":"K Grant","year":"2003","unstructured":"Grant K, Loizidou M, Taylor I (2003) Endothelin-1: a multifunctional molecule in cancer. Br J Cancer 88:163\u2013166. doi: 10.1038\/sj.bjc.6700750","journal-title":"Br J Cancer"},{"key":"593_CR7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353\u2013364. doi: 10.1016\/S0092-8674(00)80108-7","journal-title":"Cell"},{"key":"593_CR8","first-page":"4866","volume":"6","author":"K Inoue","year":"2000","unstructured":"Inoue K, Slaton JW, Karashima T, Yoshikawa C, Shuin T, Sweeney P, Millikan R, Dinney CP (2000) The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy. Clin Cancer Res 6:4866\u20134873","journal-title":"Clin Cancer Res"},{"key":"593_CR9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0090-4295(98)00658-X","volume":"53","author":"JB Nelson","year":"1999","unstructured":"Nelson JB, Nguyen SH, Wu-Wong JR, Opgenorth TJ, Dixon DB, Chung LW, Inoue N (1999) New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade. Urology 53:1063\u20131069. doi: 10.1016\/S0090-4295(98)00658-X","journal-title":"Urology"},{"key":"593_CR10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc990","volume":"3","author":"J Nelson","year":"2003","unstructured":"Nelson J, Bagnato A, Battistini B, Nisen P (2003) The endothelin axis: emerging role in cancer. Nat Rev Cancer 3:110\u2013116. doi: 10.1038\/nrc990","journal-title":"Nat Rev Cancer"},{"key":"593_CR11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0959-8049(02)00663-9","volume":"39","author":"BV Offersen","year":"2003","unstructured":"Offersen BV, Borre M, Overgaard J (2003) Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density. Eur J Cancer 39:881\u2013890. doi: 10.1016\/S0959-8049(02)00663-9","journal-title":"Eur J Cancer"},{"key":"593_CR12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1464-410X.1996.08475.x","volume":"77","author":"EA Philp","year":"1996","unstructured":"Philp EA, Stephenson TJ, Reed MW (1996) Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder. Br J Urol 77:352\u2013357","journal-title":"Br J Urol"},{"issue":"Suppl","key":"593_CR13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1042\/CS103S318S","volume":"103","author":"D Salani","year":"2002","unstructured":"Salani D, Rosano L, Di Castro V, Spinella F, Venuti A, Padley RJ, Nicotra MR, Natali PG, Bagnato A (2002) ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro. Clin Sci (Lond) 103(Suppl):318\u2013321","journal-title":"Clin Sci (Lond)"},{"key":"593_CR14","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.juro.2006.08.004","volume":"176","author":"SF Shariat","year":"2006","unstructured":"Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J Urol 176:2414\u20132422. doi: 10.1016\/j.juro.2006.08.004","journal-title":"J Urol"},{"key":"593_CR15","doi-asserted-by":"crossref","first-page":"27850","DOI":"10.1074\/jbc.M202421200","volume":"277","author":"F Spinella","year":"2002","unstructured":"Spinella F, Rosano L, Di Castro V, Natali PG, Bagnato A (2002) Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells. J Biol Chem 277:27850\u201327855. doi: 10.1074\/jbc.M202421200","journal-title":"J Biol Chem"},{"key":"593_CR16","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1158\/0008-5472.CAN-05-1403","volume":"65","author":"B Titus","year":"2005","unstructured":"Titus B, Frierson HF Jr, Conaway M, Ching K, Guise T, Chirgwin J, Hampton G, Theodorescu D (2005) Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2. Cancer 65:7320\u20137327. doi: 10.1158\/0008-5472.CAN-05-1403","journal-title":"Cancer"},{"key":"593_CR17","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","volume":"18","author":"H der Maase von","year":"2000","unstructured":"von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, Bodrogi I, Albers P, Knuth A, Lippert CM, Kerbrat P, Sanchez Rovira P, Wersall P, Cleall SP, Roychowdhury DF, Tomlin I, Visseren-Grul CM, Conte PF (2000) Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 18:3068\u20133077","journal-title":"J Clin Oncol"},{"key":"593_CR18","first-page":"223","volume":"13","author":"C Wulfing","year":"2005","unstructured":"Wulfing C, Eltze E, Piechota H, Abol-Enein H, Wulfing P, Bode ME, Hertle L, Sievert KD (2005a) Expression of endothelin-1 and endothelin-A and -B receptors in invasive bladder cancer. Oncol Rep 13:223\u2013228","journal-title":"Oncol Rep"},{"key":"593_CR19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.eururo.2004.12.019","volume":"47","author":"C Wulfing","year":"2005","unstructured":"Wulfing C, Eltze E, Yamini J, Wulfing P, Bierer S, Bocker W, Hertle L, Semjonow A, Sievert KD (2005b) Expression of the endothelin axis in bladder cancer: relationship to clinicopathologic parameters and long-term survival. Eur Urol 47:593\u2013600. doi: 10.1016\/j.eururo.2004.12.019","journal-title":"Eur Urol"},{"key":"593_CR20","first-page":"1520","volume":"47","author":"P Wulfing","year":"2005","unstructured":"Wulfing P, Persigehl T, Meyer V, G\u00f6tte M, Bremer C, Kiesel L (2005c) Targeting the endothelin-A-receptor inhibits breast carcinoma growth in vivo. Proc Am Assoc Cancer Res 47:1520","journal-title":"Proc Am Assoc Cancer Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-009-0593-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-009-0593-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-009-0593-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T02:07:05Z","timestamp":1684980425000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-009-0593-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,9]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["593"],"URL":"https:\/\/doi.org\/10.1007\/s00432-009-0593-5","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,9]]}}}